COVID-19 Pediatric Vaccine Approval Process

The Governor's Council on Disabilities and Special Education shares this information on behalf of Alaska Health and Social Services.

 

The two-dose pediatric Pfizer COVID-19 vaccine was recommended for children age 5-11 by the CDC’s Advisory Committee on Immunization Practices (ACIP), and that recommendation was also endorsed by the CDC. This follows the FDA’s emergency use authorization of the pediatric vaccine. Children age 5-11 are now eligible to receive the COVID-19 vaccine. For more information and to find a vaccine provider, visit covidvax.alaska.gov.

 

Description of photo below:

Title: PHIZER

Subtitle: COVID-19 Pediatric Vaccine Approval Process.

Picture of a box checked. FDA Advisory Panel Recommendation. An FDA vaccine advisory panel committee recommends the COVID-19 pediatric vaccine for children ages 5 through 11.

Picture of a box checked. FDA Authorization. Following the FDA vaccine advisory committee recommendation, the FDA authorizes the emergency use (EAU) of the pediatric vaccine.

Picture of a box checked. CDC Advisory Committee Recommendation. The CDC's Advisory Committee on Immunization Practices (ACIP) meets to discuss and recommend the FDA authorization.

Picture of a box checked. CDC Approval. Following the ACIP meeting, the CDC approves the recommendation.

Picture of a box checked. Pediatric Vaccine Available for Eligible Alaskans. After all the above boxes are checked, Alaska’s vaccine providers can begin administering the pediatric COVID-19 vaccine to children ages 5 through 11.